These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 8185169)
1. The cholecystokinin hypothesis of anxiety and panic disorder. Bradwejn J; Koszycki D Ann N Y Acad Sci; 1994 Mar; 713():273-82. PubMed ID: 8185169 [No Abstract] [Full Text] [Related]
2. Cholecystokinin and panic disorder: past and future clinical research strategies. Bradwejn J; Koszycki D Scand J Clin Lab Invest Suppl; 2001; 234():19-27. PubMed ID: 11713976 [TBL] [Abstract][Full Text] [Related]
3. On the significance of cholecystokinin receptors in panic disorder. van Megen HJ; den Boer JA; Westenberg HG Prog Neuropsychopharmacol Biol Psychiatry; 1994 Dec; 18(8):1235-46. PubMed ID: 7863014 [TBL] [Abstract][Full Text] [Related]
4. Pentagastrin infusions in patients with panic disorder. I. Symptoms and cardiovascular responses. Abelson JL; Nesse RM Biol Psychiatry; 1994 Jul; 36(2):73-83. PubMed ID: 7948449 [TBL] [Abstract][Full Text] [Related]
11. Glyoxalase-I mRNA expression and CCK-4 induced panic attacks. Eser D; Uhr M; Leicht G; Asmus M; Länger A; Schüle C; Baghai TC; Mulert C; Rupprecht R J Psychiatr Res; 2011 Jan; 45(1):60-3. PubMed ID: 20542521 [TBL] [Abstract][Full Text] [Related]
12. Impact of state and trait anxiety on the panic response to CCK-4. Eser D; Wenninger S; Baghai T; Schüle C; Rupprecht R J Neural Transm (Vienna); 2008 Jun; 115(6):917-20. PubMed ID: 18414777 [TBL] [Abstract][Full Text] [Related]
13. The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients. van Megen HJ; Westenberg HG; den Boer JA; Slaap B; van Es-Radhakishun F; Pande AC Psychopharmacology (Berl); 1997 Feb; 129(3):243-8. PubMed ID: 9084062 [TBL] [Abstract][Full Text] [Related]
14. [Is cholecystokinin a biological support in panic attacks?]. Bourin M; Bradwejn J; Koszycki D Encephale; 1991; 17(5):475-9. PubMed ID: 1686250 [TBL] [Abstract][Full Text] [Related]
15. Two faces of cholecystokinin: anxiety and schizophrenia. Bourin M; Malinge M; Vasar E; Bradwejn J Fundam Clin Pharmacol; 1996; 10(2):116-26. PubMed ID: 8737954 [TBL] [Abstract][Full Text] [Related]
16. Neurobiological investigations into the role of cholecystokinin in panic disorder. Bradwejn J J Psychiatry Neurosci; 1993 Jul; 18(4):178-88. PubMed ID: 8104032 [TBL] [Abstract][Full Text] [Related]
18. Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats. Bertoglio LJ; Zangrossi H Brain Res; 2005 Oct; 1059(1):46-51. PubMed ID: 16168394 [TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin induces cerebral vasodilatation via presynaptic CCK2 receptors: new implications for the pathophysiology of panic. Sánchez-Fernández C; González C; Mercer LD; Beart PM; Ruiz-Gayo M; Fernández-Alfonso MS J Cereb Blood Flow Metab; 2003 Mar; 23(3):364-70. PubMed ID: 12621311 [TBL] [Abstract][Full Text] [Related]
20. One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: investigation of neural correlates with BOLD MRI. Schunck T; Mathis A; Erb G; Namer IJ; Hode Y; Demazières A; Luthringer R J Psychopharmacol; 2011 Jan; 25(1):52-9. PubMed ID: 20498136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]